Drug Profile
3 VM 1001 topical cream - CDA Research Group
Alternative Names: 3VM-1001; 3VM1001 cream - CDA Research GroupLatest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator CDA Research Group
- Class Analgesics; Antirheumatics; Osteoporosis therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Pain
- No development reported Osteoarthritis
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for phase-I development in Osteoarthritis in USA (Topical, Cream)
- 30 Mar 2018 CDA Research Group completes a phase I trial for Post-herpetic neuralgia in USA (Topical) (NCT03421613)
- 29 May 2017 NCT03142178 - QC feedback incorporated